NEW YORK (WABC) -- According to a survey by the Partnership for New York City, 75% of employers delayed their return to office plans due to the omicron surge. 38% of employers expect daily office ...
NEW YORK -- The use of some monoclonal antibody treatments against COVID is now being discouraged, and updated guidelines from the NIH COVID Treatment Panel say Regeneron and Eli Lilly's treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results